z-logo
open-access-imgOpen Access
Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series
Author(s) -
Emiliano Calvi,
Nicola Bernardi,
Giuliana Cimino,
Greta Pascariello,
Pompilio Faggiano,
Emanuele Gavazzi,
Enrico Vizzardi,
Marco Metra
Publication year - 2020
Publication title -
european heart journal - case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.256
H-Index - 5
ISSN - 2514-2119
DOI - 10.1093/ehjcr/ytaa518
Subject(s) - medicine , intracardiac injection , thrombosis , pulmonary embolism , cardiology , venous thrombosis , radiology , magnetic resonance imaging
Background COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. Case summary We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed evidence of unusual intracardiac thrombosis with thrombi adherent to regularly contracting walls. Discussion This evidence confirms that COVID-19 induces a hypercoagulable state which can result in intracardiac thrombosis. Therefore, TTE is indicated in all COVID-19 patients for early diagnosis, and prompt anticoagulant therapy is to be considered as a thromboprophylaxis strategy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom